2014;18:897C915
2014;18:897C915. diagnosed MM newly. We did not see manifestation difference between NPC and MGUS (p=0.65), however, TRIP13 was significantly increased in newly diagnosed MM individuals compared to NPC and MGUS samples (p
Supplementary Materials1
Supplementary Materials1. segregating prostate malignancy individuals into those Tegafur requiring therapeutic intervention and those who can be adopted are inadequate. Xiong et al. display that KLF4 and its downstream targets make up a gene signature that identifies indolent tumors. This approach may SPRY1 improve prognosis and determine restorative focuses on for advanced malignancy. INTRODUCTION Prostate…